a new standard of care in recurrent ovarian cancer?
Published 6 years ago • 228 plays • Length 6:38Download video MP4
Download video MP3
Similar videos
-
7:16
new options for recurrent ovarian cancer
-
7:38
parp maintenance therapy in recurrent ovarian cancer
-
9:08
factors in choice of treatment for recurrent ovarian cancer
-
1:34
dr. birrer discusses recurrent ovarian cancer treatment
-
1:38
dr. dalton on the standard of care in ovarian cancer
-
6:15
the gog-0213 trial in recurrent ovarian cancer
-
4:07
expert approaches for treating recurrent ovarian cancer
-
1:25
dr. konecny on the indications for parp inhibitors in recurrent ovarian cancer
-
1:30
dr. mirza on the evolving treatment landscape in recurrent ovarian cancer
-
33:15
ovarian cancer: standards of care and new opportunities - dr. robert coleman
-
26:02
updates in ovarian cancer: frontline maintenance
-
6:04
when to add bevacizumab for recurrent ovarian cancer
-
6:03
olaparib maintenance for recurrent ovarian cancer
-
5:27
recurrent ovarian cancer; considerations beyond the platinum-free interval
-
6:20
parp inhibitors in recurrent ovarian cancer
-
7:09
biomarker-driven frontline ovarian cancer treatment
-
1:47
dr. liu on parp inhibitors in recurrent ovarian cancer
-
2:18
dr. mirza on efficacy of niraparib/bevacizumab combo in recurrent ovarian cancer
-
8:26
the impact of paola-1 on frontline treatment of ovarian cancer